Merus N.V. (MRUS) NASDAQ
$50.63 0.95 (1.91%)
Market Cap: $3.45B
As of 09/11/24 03:17 PM EDT. Market open.
Merus N.V. (MRUS)
NASDAQ
$50.63
0.95 (1.91%)
Market Cap: $3.45B
As of 09/11/24 03:17 PM EDT. Market open.
Add to Portfolio
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Sven Ante Lundberg M.D.
Full Time Employees
172
CEO Compensation (Base)
$581,847
CEO Compensation (Total)
$7.54M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Sven Ante Lundberg M.D.
Full Time Employees
172
CEO Compensation (Base)
$581,847
CEO Compensation (Total)
$7.54M
URL
Address
Yalelaan 62, Utrecht, 3584 CM.
PRICE CHART FOR MERUS N.V.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$49.41
Previous Close
$49.68
Days Range
$49.41 - $51.34
52 week range
$19.81 - $61.61
Volume
383,870
Avg. Volume (30 days)
637,435
Market Cap
$3.45B
Dividend Yield
-
P/E
(17.52)
Shares Outstanding
68,210,500
Open
$49.41
Previous Close
$49.68
Days Range
$49.41 - $51.34
52 week range
$19.81 - $61.61
Volume
383,870
Avg. Volume (30 days)
637,435
Market Cap
$3.45B
Dividend Yield
-
P/E
(17.52)
Shares Outstanding
68,210,500
FINANCIAL STATEMENTS FOR MERUS N.V.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MERUS N.V.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Shuman Harry | VP Controller, PAO | Aug 21, 2024 | Sale | $54.00 | 2,500 | 135,000 | 7,002 | Aug 22, 2024, 04:03 PM |
| Shuman Harry | VP Controller, PAO | Aug 20, 2024 | Sale | $54.00 | 2,500 | 135,000 | 7,002 | Aug 22, 2024, 04:03 PM |
| Silverman Peter B. | COO & GC | Jun 27, 2024 | Option Exercise | $17.94 | 10,000 | 179,400 | 10,000 | Jun 28, 2024, 04:05 PM |
| Silverman Peter B. | COO & GC | Jun 27, 2024 | Sale | $60.00 | 10,000 | 600,000 | 0 | Jun 28, 2024, 04:05 PM |
| Silverman Peter B. | COO & GC | Jun 17, 2024 | Option Exercise | $24.36 | 62,000 | 1,510,280 | 62,000 | Jun 20, 2024, 04:30 PM |
| Silverman Peter B. | COO & GC | Jun 17, 2024 | Sale | $56.52 | 62,000 | 3,504,178 | 0 | Jun 20, 2024, 04:30 PM |
| Shuman Harry | VP Controller, PAO | Jun 12, 2024 | Sale | $57.84 | 7,300 | 422,232 | 7,002 | Jun 12, 2024, 05:02 PM |
| Shuman Harry | VP Controller, PAO | Jun 10, 2024 | Sale | $53.22 | 1,000 | 53,224 | 7,002 | Jun 12, 2024, 05:02 PM |
| Shuman Harry | VP Controller, PAO | Jun 04, 2024 | Sale | $52.89 | 6,000 | 317,354 | 7,002 | Jun 06, 2024, 04:05 PM |
| Shuman Harry | VP Controller, PAO | Dec 19, 2023 | Sale | $26.68 | 115 | 3,068 | 7,002 | Dec 20, 2023, 04:05 PM |
| Silverman Peter B. | COO & GC | Dec 15, 2023 | Sale | $25.00 | 22,386 | 559,650 | 0 | Dec 18, 2023, 05:15 PM |
| Shuman Harry | VP Controller, PAO | Dec 08, 2023 | Sale | $24.44 | 250 | 6,110 | 7,117 | Dec 12, 2023, 04:04 PM |
| Shuman Harry | VP Controller, PAO | Dec 01, 2023 | Sale | $24.58 | 575 | 14,133 | 7,367 | Dec 04, 2023, 04:05 PM |
| Shuman Harry | VP Controller, PAO | Jun 01, 2023 | Sale | $21.48 | 575 | 12,351 | 5,442 | Jun 01, 2023, 04:21 PM |
| Iwicki Mark T | Director | Apr 14, 2023 | Option Exercise | $7.27 | 73,576 | 534,679 | 73,576 | Apr 17, 2023, 08:26 AM |
| Liu Hui | EVP, CBO & Head of Merus US | Apr 06, 2023 | Option Exercise | $7.86 | 98,085 | 770,948 | 156,016 | Apr 10, 2023, 12:43 PM |
| Shuman Harry | VP Controller, PAO | Dec 13, 2022 | Sale | $13.85 | 168 | 2,327 | 3,517 | Dec 14, 2022, 04:45 PM |
| Shuman Harry | VP Controller, PAO | Dec 01, 2022 | Sale | $15.35 | 575 | 8,826 | 3,685 | Dec 01, 2022, 04:34 PM |
| Lundberg Sven Ante | President, CEO & PFO | Nov 03, 2022 | Buy | $14.38 | 14,706 | 211,431 | 40,576 | Nov 03, 2022, 02:07 PM |
| Shuman Harry | VP Controller, PAO | Aug 25, 2022 | Sale | $24.33 | 165 | 4,014 | 1,760 | Aug 29, 2022, 10:13 AM |
| Lundberg Sven Ante | President, CEO & PFO | Aug 22, 2022 | Buy | $22.92 | 5,826 | 133,558 | 25,870 | Aug 23, 2022, 04:09 PM |
| Lundberg Sven Ante | President, CEO & PFO | Aug 19, 2022 | Buy | $22.99 | 704 | 16,187 | 20,044 | Aug 22, 2022, 03:02 PM |
| Lundberg Sven Ante | President, CEO & PFO | Jul 12, 2022 | Buy | $22.97 | 4,340 | 99,685 | 19,340 | Jul 13, 2022, 10:13 AM |
| Shuman Harry | VP Controller, PAO | Jun 01, 2022 | Sale | $18.31 | 575 | 10,528 | 1,925 | Jun 03, 2022, 04:00 PM |
| Silverman Peter B. | EVP, GC and Head of Utrecht | Mar 10, 2022 | Option Exercise | $11.16 | 60,000 | 669,600 | 60,000 | Mar 11, 2022, 02:34 PM |
| Silverman Peter B. | EVP, GC and Head of Utrecht | Mar 10, 2022 | Sale | $26.95 | 60,000 | 1,617,000 | 0 | Mar 11, 2022, 02:34 PM |
| BVF PARTNERS L P/IL | 10% Owner | Oct 07, 2021 | Sale | $27.53 | 985,447 | 27,130,439 | 2,165,675 | Oct 08, 2021, 09:24 PM |
| BVF PARTNERS L P/IL | 10% Owner | Oct 08, 2021 | Sale | $27.79 | 147,267 | 4,092,035 | 2,085,664 | Oct 08, 2021, 09:24 PM |
| de Kruif John | SVP & Chief Technology Officer | Aug 12, 2021 | Sale | $19.34 | 2,787 | 53,901 | 15,282 | Aug 16, 2021, 09:24 AM |
| Lundberg Sven Ante | President, CEO & PFO | Aug 02, 2021 | Option Exercise | $13.36 | 15,000 | 200,474 | 15,000 | Aug 04, 2021, 03:56 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jul 02, 2021 | Sale | $20.75 | 2,186,022 | 45,359,957 | 2,696,674 | Jul 07, 2021, 04:49 PM |
| Bakker Lex | SVP, Chief Development Officer | Jul 02, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 15,668 | Jul 07, 2021, 11:35 AM |
| Bakker Lex | SVP, Chief Development Officer | Jul 01, 2021 | Sale | $21.05 | 3,860 | 81,242 | 10,428 | Jul 06, 2021, 12:00 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 30, 2021 | Buy | $19.75 | 300,000 | 5,925,000 | 3,803,152 | Apr 01, 2021, 05:18 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 22, 2021 | Buy | $22.75 | 79,500 | 1,808,625 | 3,638,152 | Mar 24, 2021, 05:15 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 16, 2021 | Buy | $23.00 | 250,000 | 5,749,900 | 3,566,396 | Mar 18, 2021, 06:07 PM |
| Lundberg Sven Ante | President, CEO & PFO | Mar 01, 2021 | Option Exercise | $13.38 | 74,000 | 989,867 | 74,000 | Mar 03, 2021, 12:00 AM |
| BVF PARTNERS L P/IL | 10% Owner | Jan 21, 2021 | Buy | $24.75 | 844,680 | 20,905,830 | 3,513,335 | Jan 25, 2021, 06:51 PM |
| INCYTE CORP | 10% Owner | Jan 25, 2021 | Option Exercise | $24.75 | 350,000 | 8,662,500 | 3,550,000 | Jan 25, 2021, 04:48 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 18, 2020 | Buy | $16.05 | 160,000 | 2,568,000 | 3,055,521 | Dec 22, 2020, 07:04 PM |
| BVF PARTNERS L P/IL | 10% Owner | Sep 15, 2020 | Buy | $11.75 | 146,754 | 1,724,360 | 2,940,553 | Sep 17, 2020, 07:42 PM |
| BVF PARTNERS L P/IL | 10% Owner | Sep 10, 2020 | Buy | $11.10 | 189,651 | 2,104,785 | 2,862,802 | Sep 14, 2020, 08:14 PM |
| BVF PARTNERS L P/IL | 10% Owner | Sep 03, 2020 | Buy | $11.17 | 201,906 | 2,255,290 | 2,762,341 | Sep 08, 2020, 07:08 PM |
| Throsby Mark | EVP & Chief Scientific Officer | Jul 07, 2020 | Sale | $15.46 | 368 | 5,689 | 45,515 | Jul 09, 2020, 04:00 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jun 08, 2020 | Buy | $15.20 | 87,254 | 1,326,261 | 2,657,514 | Jun 10, 2020, 07:03 PM |
| Throsby Mark | EVP & Chief Scientific Officer | Jun 02, 2020 | Sale | $14.19 | 368 | 5,222 | 45,175 | Jun 04, 2020, 04:00 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jun 01, 2020 | Buy | $14.00 | 1,462,510 | 20,475,140 | 2,610,548 | Jun 03, 2020, 06:17 PM |
| Throsby Mark | EVP & Chief Scientific Officer | May 06, 2020 | Sale | $14.54 | 368 | 5,351 | 44,835 | May 11, 2020, 08:00 AM |
| Throsby Mark | EVP & Chief Scientific Officer | Apr 02, 2020 | Sale | $10.93 | 368 | 4,022 | 44,495 | Apr 06, 2020, 04:00 PM |
| Throsby Mark | EVP & Chief Scientific Officer | Mar 04, 2020 | Sale | $18.10 | 368 | 6,661 | 44,155 | Mar 10, 2020, 05:00 PM |
| Throsby Mark | EVP & Chief Scientific Officer | Feb 24, 2020 | Sale | $17.74 | 57,088 | 1,012,741 | 43,815 | Feb 26, 2020, 09:17 PM |
| de Kruif John | SVP & Chief Technology Officer | Feb 18, 2020 | Sale | $18.98 | 1,268 | 24,067 | 11,649 | Feb 20, 2020, 05:00 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jan 16, 2020 | Buy | $16.15 | 278,730 | 4,501,489 | 1,804,105 | Jan 21, 2020, 05:21 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jan 13, 2020 | Buy | $14.98 | 83,962 | 1,257,616 | 1,657,663 | Jan 15, 2020, 06:32 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Shuman Harry | VP Controller, PAO | 08/21/2024 | 135,000 |
| Shuman Harry | VP Controller, PAO | 08/20/2024 | 135,000 |
| Silverman Peter B. | COO & GC | 06/27/2024 | 179,400 |
| Silverman Peter B. | COO & GC | 06/27/2024 | 600,000 |
| Silverman Peter B. | COO & GC | 06/17/2024 | 1,510,280 |
| Silverman Peter B. | COO & GC | 06/17/2024 | 3,504,178 |
| Shuman Harry | VP Controller, PAO | 06/12/2024 | 422,232 |
| Shuman Harry | VP Controller, PAO | 06/10/2024 | 53,224 |
| Shuman Harry | VP Controller, PAO | 06/04/2024 | 317,354 |
| Shuman Harry | VP Controller, PAO | 12/19/2023 | 3,068 |
| Silverman Peter B. | COO & GC | 12/15/2023 | 559,650 |
| Shuman Harry | VP Controller, PAO | 12/08/2023 | 6,110 |
| Shuman Harry | VP Controller, PAO | 12/01/2023 | 14,133 |
| Shuman Harry | VP Controller, PAO | 06/01/2023 | 12,351 |
| Iwicki Mark T | Director | 04/14/2023 | 534,679 |
| Liu Hui | EVP, CBO & Head of Merus US | 04/06/2023 | 770,948 |
| Shuman Harry | VP Controller, PAO | 12/13/2022 | 2,327 |
| Shuman Harry | VP Controller, PAO | 12/01/2022 | 8,826 |
| Lundberg Sven Ante | President, CEO & PFO | 11/03/2022 | 211,431 |
| Shuman Harry | VP Controller, PAO | 08/25/2022 | 4,014 |
| Lundberg Sven Ante | President, CEO & PFO | 08/22/2022 | 133,558 |
| Lundberg Sven Ante | President, CEO & PFO | 08/19/2022 | 16,187 |
| Lundberg Sven Ante | President, CEO & PFO | 07/12/2022 | 99,685 |
| Shuman Harry | VP Controller, PAO | 06/01/2022 | 10,528 |
| Silverman Peter B. | EVP, GC and Head of Utrecht | 03/10/2022 | 669,600 |
| Silverman Peter B. | EVP, GC and Head of Utrecht | 03/10/2022 | 1,617,000 |
| BVF PARTNERS L P/IL | 10% Owner | 10/07/2021 | 27,130,439 |
| BVF PARTNERS L P/IL | 10% Owner | 10/08/2021 | 4,092,035 |
| de Kruif John | SVP & Chief Technology Officer | 08/12/2021 | 53,901 |
| Lundberg Sven Ante | President, CEO & PFO | 08/02/2021 | 200,474 |
| BVF PARTNERS L P/IL | 10% Owner | 07/02/2021 | 45,359,957 |
| Bakker Lex | SVP, Chief Development Officer | 07/02/2021 | 13,510 |
| Bakker Lex | SVP, Chief Development Officer | 07/01/2021 | 81,242 |
| BVF PARTNERS L P/IL | 10% Owner | 03/30/2021 | 5,925,000 |
| BVF PARTNERS L P/IL | 10% Owner | 03/22/2021 | 1,808,625 |
| BVF PARTNERS L P/IL | 10% Owner | 03/16/2021 | 5,749,900 |
| Lundberg Sven Ante | President, CEO & PFO | 03/01/2021 | 989,867 |
| BVF PARTNERS L P/IL | 10% Owner | 01/21/2021 | 20,905,830 |
| INCYTE CORP | 10% Owner | 01/25/2021 | 8,662,500 |
| BVF PARTNERS L P/IL | 10% Owner | 12/18/2020 | 2,568,000 |
| BVF PARTNERS L P/IL | 10% Owner | 09/15/2020 | 1,724,360 |
| BVF PARTNERS L P/IL | 10% Owner | 09/10/2020 | 2,104,785 |
| BVF PARTNERS L P/IL | 10% Owner | 09/03/2020 | 2,255,290 |
| Throsby Mark | EVP & Chief Scientific Officer | 07/07/2020 | 5,689 |
| BVF PARTNERS L P/IL | 10% Owner | 06/08/2020 | 1,326,261 |
| Throsby Mark | EVP & Chief Scientific Officer | 06/02/2020 | 5,222 |
| BVF PARTNERS L P/IL | 10% Owner | 06/01/2020 | 20,475,140 |
| Throsby Mark | EVP & Chief Scientific Officer | 05/06/2020 | 5,351 |
| Throsby Mark | EVP & Chief Scientific Officer | 04/02/2020 | 4,022 |
| Throsby Mark | EVP & Chief Scientific Officer | 03/04/2020 | 6,661 |
| Throsby Mark | EVP & Chief Scientific Officer | 02/24/2020 | 1,012,741 |
| de Kruif John | SVP & Chief Technology Officer | 02/18/2020 | 24,067 |
| BVF PARTNERS L P/IL | 10% Owner | 01/16/2020 | 4,501,489 |
| BVF PARTNERS L P/IL | 10% Owner | 01/13/2020 | 1,257,616 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MERUS N.V.
CHANGE IN SHARES OUTSTANDING FOR MERUS N.V.
STOCK BUYBACKS FOR MERUS N.V.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.45%
1Q
09/30/2023
7.83%
2Q
06/30/2023
20.21%
3Q
03/31/2023
25.39%
4Q
12/31/2022
25.40%
5Q
09/30/2022
26.12%
6Q
06/30/2022
33.11%
7Q
03/31/2022
33.56%
8Q
12/31/2021
40.20%
9Q
09/30/2021
50.82%
10Q
06/30/2021
51.36%
11Q
03/31/2021
60.41%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MERUS N.V.
LOADING...